{"id":1030343,"date":"2010-05-20T08:15:13","date_gmt":"2010-05-20T08:15:13","guid":{"rendered":"http:\/\/www.immortalitymedicine.tv\/fast-release-orodispersible-tramadol-as-analgesia-in-hysterosalpingography-with-a-metal-cannula-or-a-balloon-catheter\/"},"modified":"2024-08-17T14:57:41","modified_gmt":"2024-08-17T18:57:41","slug":"fast-release-orodispersible-tramadol-as-analgesia-in-hysterosalpingography-with-a-metal-cannula-or-a-balloon-catheter","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/human-reproduction\/fast-release-orodispersible-tramadol-as-analgesia-in-hysterosalpingography-with-a-metal-cannula-or-a-balloon-catheter.php","title":{"rendered":"Fast-release orodispersible tramadol as analgesia in hysterosalpingography with a metal cannula or a balloon catheter"},"content":{"rendered":"<p>BACKGROUND<\/p>\n<p>This study aimed to evaluate the potential benefit, in terms of pain relief, of the new oral fast-release orodispersible galvanic form of tramadol in women undergoing hysterosalpingography (HSG) with either a metal cannula or a balloon catheter.<\/p>\n<p>METHODS<\/p>\n<p>In a randomized, double-blind, placebo-controlled, 2 x 2 factorial-design trial, conducted at a single academic centre, 128 women were assigned into groups: (I) tramadol and a metal cannula, (II) tramadol and a balloon catheter, (III) placebo and a metal cannula or (IV) placebo and a balloon catheter. The primary end-point was pain registered by the patients on 10-cm visual analogue scales (VASs) at various times during and after the procedure. Secondary end-points included side effects and pain as assessed by the same physician during HSG.<\/p>\n<p>RESULTS<\/p>\n<p>The main effect of tramadol versus placebo medication (i.e. I and II versus III and IV) was a statistically significant difference (<I>P<\/I> &lt; 0.001) in self-reported VAS of &ndash;0.91 (&ndash;1.35 to &ndash;0.47) on the absolute and &ndash;33% (&ndash;48% to &ndash;17%) on the relative scale in favour of tramadol. Likewise, there was a significant benefit for tramadol against placebo medication for physician-perceived VAS pain scores (39% relative reduction; <I>P<\/I> &lt; 0.001). The main effect of the balloon catheter versus metal cannula (i.e. II and IV versus I and III) was a non-significant (<I>P<\/I> = 0.82) difference in patient-reported VAS of &ndash;0.05 (&ndash;0.49 to +0.39) and &ndash;2% (&ndash;21% to +17%). There were no medication&ndash;HSG device interactions and no differences in side effects.<\/p>\n<p>CONCLUSIONS<\/p>\n<p>During and after HSG, fast-release orodispersible tramadol significantly reduces pain without increasing side effects.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>BACKGROUND This study aimed to evaluate the potential benefit, in terms of pain relief, of the new oral fast-release orodispersible galvanic form of tramadol in women undergoing hysterosalpingography (HSG) with either a metal cannula or a balloon catheter. METHODS In &hellip; <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/human-reproduction\/fast-release-orodispersible-tramadol-as-analgesia-in-hysterosalpingography-with-a-metal-cannula-or-a-balloon-catheter.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246857],"tags":[],"class_list":["post-1030343","post","type-post","status-publish","format-standard","hentry","category-human-reproduction"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1030343"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1030343"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1030343\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1030343"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1030343"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1030343"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}